No abstract

Animal food sources provide human beings with minerals considerably in adequate quantities. Fish is an indispensable reliable source of nutrients, as aquaculture is a sector that is fast growing and which provides 50% of the world's fish production. However, fish production is hampered by the increasing costs of feeds due to the ever rising cost of fish meal, an integral component of fish feeds. Substituting fish meal with cheap, yet highly nutritious ingredients in fish feeds is therefore paramount. This study investigated the effects of substituting fish meal with adult cricket meal (ACM) and black soldier fly meal (BSFM) on minerals content of extruded fish feeds, where four levels of substitution (0, 25, 50 and 75%) were used. The effect of feed moisture content on minerals was also studied where 20 and 30% feed moisture levels were used. Leaching effects of the pellets were studied as well. The results showed a significant increase (P \ 0.05) in the levels of phosphorus and potassium as the level of fish meal substitution increased from 0 to 75%. On the other hand, iron and sodium levels reduced significantly (P \ 0.05) as the level of fish meal substitution increased. Magnesium content increased with increasing level of substitution with BSFM, but decreased with increasing level of substitution with ACM. Copper, zinc and manganese were not greatly influenced by levels of fish meal substitution. Diets that had zero substitution showed higher leaching effect for most minerals than diets that were substituted with 75% ACM or BSFM. This study found that both ACM and BSFM can be used to substitute fish meal in fish feeds and obtain adequate mineral profile and low leaching effect.

Our aim was to systematically identify and compare how generic medications, as defined by the US Food and Drug Administration (FDA), World Health Organization (WHO), and European Medicines Agency (EMA), are classified and defined by regulatory agencies around the world. We focused on emerging markets and selected the most populated countries in each of the WHO regions: Africa, the Americas, Eastern Mediterranean, Europe, Southeast Asia, and Western Pacific. A structured review of published literature was performed through December 2013. Direct information from regulatory agencies and Ministries of Health for each country was extracted. Additionally, key informant interviews were performed for validation. Of the 21 countries selected, approximately half provided an official country-level definition for generic pharmaceuticals. The others did not have any definition or referred to the WHO. Only two-thirds of the countries had specific requirements for generic pharmaceuticals, often associated with clinical interchangeability. Most countries with requirements mention bioequivalence, but few required bioavailability studies explicitly. Over 30 % of the countries had other terms associated with generics in their definitions and processes. In countries with generic drug policies, there is reference to patent and/or data protection during the drug registration process. Several countries do not mention good manufacturing practices as part of the evaluation process. Countries in Africa and Eastern Mediterranean regions appear to have a less developed regulatory framework. In summary, there is significant variability in the definition and classification of generic drugs in emerging markets. Standardization of the definitions is necessary to make international comparisons viable.

No abstract

Abstract— The increase in the release of acetylcholine (ACh) from cortical slices of rat brain elicited by the depolarizing agents, ouabain and tityustoxin (TsTX) was compared in the presence of tetrodotoxin, an inhibitor of Na+ transport and of ethyleneglycol tetraacetic acid, a specific chelator of Ca2+. TsTX stimulated the release of ACh independently of K1 but required both Na+ and Ca2+. Unlike ouabain, TsTX failed to inhibit the Na+, K+ ‐ATPase of rat brain homogenates. The uptake of 24Na+ and of 45Ca2+ by the slices was significantly enhanced by TsTX over the entire incubation period during which this process was compared to TsTX‐free controls. A hypothesis of TsTX action is proposed which differs from that necessary to explain the ACh releasing effect of ouabain.